CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...

(Nanowerk Spotlight) For decades, microfluidics has held promise as a revolutionary technology, yet widespread adoption outside research labs has remained elusive. Microfluidic devices enable precise ...

Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...

Amidst the crackle of cellular signaling, it can be hard to distinguish between cells that are quick on the draw, and those that take a long time “drawing a bead” before they finally fire. When the ...

A new high-throughput surface plasmon resonance (SPR) technology for the analysis of binding interactions has been released with a host of new developments to improve the process. SPR is a key ...

A new sensor has been designed by Massachusetts Institute of Technology researchers and it could significantly accelerate the process of diagnosing sepsis. Sepsis is a serious complication of an ...

CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, are pleased to announce the ...

UK-based biotech firm Nuclera has announced it has acquired Taiwan-based E Ink Holdings (EIH)'s digital microfluidics unit to form its US subsidiary. Combining the technologies of the two companies ...